Natural Capsules Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)
Natural Capsules Ltd · Financial Result · 14 Nov 2026, 12:28 am
Natural Capsules Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 5,115 (+11.7% YoY | +5.0% QoQ) ■ EBITDA: 301 (Loss to Profit YoY | +168.5% QoQ) ■ EBITDA Margin (%): 5.9 (Loss to Profit YoY | +358 bps QoQ) ■ PAT: -122 (+69.2% YoY | +55.1% QoQ) ■ EPS (INR): -4.07 (+39.8% YoY | +26.5% QoQ) Natural Capsules Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) Segmental Performance Capsules ■ Revenue: 4,748 (+6.5% YoY | +10.4% QoQ) ■ EBIT: 788 (+53.0% YoY | +10.9% QoQ) ■ EBIT Margin (%): 16.6 (+504 bps YoY | +9 bps QoQ) API ■ Revenue: 367 (+200.4% YoY | -35.5% QoQ) ■ EBIT: -727 (+15.4% YoY | +9.6% QoQ) ■ EBIT Margin (%): -198 (+50504 bps YoY | -5675 bps QoQ)
Original exchange filing (PDF)
More announcements from Natural Capsules Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sunil Laxminarayana Mundra · 16 Nov 2026
- Please find enclosed herewith copy of Investor Presentation in connection with Q2 Financial Results. · 16 Nov 2026
- Please find enclosed herewith Press Release made to Investors and Analysts in connection with Q2 Financials. · 16 Nov 2026
- Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Company will hold .... · 19 Nov 2026
- We wish to inform you that due to an inadvertent typographical error in the decimal placement in the Consolidated Segment- Wise Revenue, Results & Capital Employed statement we are submitting .... · 15 Nov 2026
- Approve the Allotment of Securities on Preferential Basis. · 14 Nov 2026
- In order to close the matter and maintain compliance harmony, the company has deposited the requisite fine amount as demanded by the Stock Exchanges. · 14 Nov 2026
- 1. Approved the Unaudited Consolidated & Standalone Financial Results of the Company for the Quarter and Half Yearly ended September, 2026. 2. Approved the Allotment of Securities on .... · 14 Nov 2026
